Hakutulokset - Kevin P. Foley

Tarkenna hakua
  1. 1
    Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation

    Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation Tekijä Kevin P. Foley

    Julkaistu 1998
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic confirmation of promoter competition during globin gene switching.

    Individual stage selector element mutations lead to reciprocal changes in beta- vs. epsilon-globin gene transcription: genetic confirmation of promoter competition during globin ge... Tekijä Kevin P. Foley, Jason D. Engel

    Julkaistu 1992
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    The beta-globin stage selector element factor is erythroid-specific promoter/enhancer binding protein NF-E4.

    The beta-globin stage selector element factor is erythroid-specific promoter/enhancer binding protein NF-E4. Tekijä James Gallarda, Kevin P. Foley, Z Y Yang, James Douglas Engel

    Julkaistu 1989
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Blau Syndrome, the prototypic auto-inflammatory granulomatous disease

    Blau Syndrome, the prototypic auto-inflammatory granulomatous disease Tekijä Carine Wouters, Anne Maes, Kevin P. Foley, John Bertin, Carlos D. Rosé

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Myosin Va mediates Rab8A-regulated GLUT4 vesicle exocytosis in insulin-stimulated muscle cells

    Myosin Va mediates Rab8A-regulated GLUT4 vesicle exocytosis in insulin-stimulated muscle cells Tekijä Yi Sun, Tim Chiu, Kevin P. Foley, Philip J. Bilan, Amira Klip

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes

    Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes Tekijä Joseph F. Cavallari, Emmanuel Denou, Kevin P. Foley, Waliul I. Khan, Jonathan D. Schertzer

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors

    The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors Tekijä Tzu‐yin Lin, Misty D. Bear, Zhenjian Du, Kevin P. Foley, Weiwen Ying, James Barsoum, Cheryl A. London

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1

    Bacterial Peptidoglycan Stimulates Adipocyte Lipolysis via NOD1 Tekijä Wendy Chi, Dyda Dao, Trevor C. Lau, Brandyn D. Henriksbo, Joseph F. Cavallari, Kevin P. Foley, Jonathan D. Schertzer

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    NOD2 Activation Induces Muscle Cell-Autonomous Innate Immune Responses and Insulin Resistance

    NOD2 Activation Induces Muscle Cell-Autonomous Innate Immune Responses and Insulin Resistance Tekijä Akhilesh K. Tamrakar, Jonathan D. Schertzer, Tim Chiu, Kevin P. Foley, Philip J. Bilan, Dana J. Philpott, Amira Klip

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Long term but not short term exposure to obesity related microbiota promotes host insulin resistance

    Long term but not short term exposure to obesity related microbiota promotes host insulin resistance Tekijä Kevin P. Foley, Soumaya Zlitni, Emmanuel Denou, Brittany M. Duggan, Rebecca W. Chan, Jennifer C. Stearns, Jonathan D. Schertzer

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer

    Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer Tekijä Cheryl A. London, Misty D. Bear, Jennifer McCleese, Kevin P. Foley, Reji Paalangara, Takayo Inoue, Weiwen Ying, James Barsoum

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Myo1c binding to submembrane actin mediates insulin-induced tethering of GLUT4 vesicles

    Myo1c binding to submembrane actin mediates insulin-induced tethering of GLUT4 vesicles Tekijä Shlomit Boguslavsky, Tim Chiu, Kevin P. Foley, César Osorio‐Fuentealba, Costin N. Antonescu, K. Ulrich Bayer, Philip J. Bilan, Amira Klip

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice

    The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice Tekijä Marin Jane McBride, Kevin P. Foley, Donna M. D’Souza, Yujin E. Li, Trevor C. Lau, Thomas J. Hawke, Jonathan D. Schertzer

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice

    Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice Tekijä Joseph F. Cavallari, Nicole G. Barra, Kevin P. Foley, Amanda J. Lee, Brittany M. Duggan, Brandyn D. Henriksbo, Fernando F. Anhê, Ali A. Ashkar, Jonathan D. Schertzer

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling

    Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling Tekijä David A. Proia, Kevin P. Foley, Tim Korbut, Jim Sang, Don Smith, Richard C. Bates, Yuan Liu, Alex Rosenberg, Dan Zhou, Keizo Koya, James Barsoum, Ronald K. Blackman

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Inflammation promotes adipocyte lipolysis via IRE1 kinase

    Inflammation promotes adipocyte lipolysis via IRE1 kinase Tekijä Kevin P. Foley, Yong Chen, Nicole G. Barra, Mark Heal, Kieran Kwok, Akhilesh K. Tamrakar, Wendy Chi, Brittany M. Duggan, Brandyn D. Henriksbo, Yong Liu, Jonathan D. Schertzer

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models

    Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models Tekijä David A. Proia, Jim Sang, Suqin He, Donald L. Smith, Manuel Sequeira, Chaohua Zhang, Yuan Liu, Shuxia Ye, Dan Zhou, Ronald K. Blackman, Kevin P. Foley, Keizo Koya, Yumiko Wada

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Adipose Tissue Inflammation Is Directly Linked to Obesity-Induced Insulin Resistance, while Gut Dysbiosis and Mitochondrial Dysfunction Are Not Required

    Adipose Tissue Inflammation Is Directly Linked to Obesity-Induced Insulin Resistance, while Gut Dysbiosis and Mitochondrial Dysfunction Are Not Required Tekijä Heather L. Petrick, Kevin P. Foley, Soumaya Zlitni, Henver S. Brunetta, Sabina Paglialunga, Paula M. Miotto, Valerie Politis‐Barber, Conor O’Dwyer, Diana J. Philbrick, Morgan D. Fullerton, Jonathan D. Schertzer, Graham P. Holloway

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy

    Ganetespib, a Unique Triazolone-Containing Hsp90 Inhibitor, Exhibits Potent Antitumor Activity and a Superior Safety Profile for Cancer Therapy Tekijä Weiwen Ying, Zhenjian Du, Lijun Sun, Kevin P. Foley, David A. Proia, Ronald K. Blackman, Dan Zhou, Takayo Inoue, Noriaki Tatsuta, Jim Sang, Shuxia Ye, Jamie Acquaviva, Luisa Shin Ogawa, Yumiko Wada, James Barsoum, Keizo Koya

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance

    Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance Tekijä Brandyn D. Henriksbo, Trevor C. Lau, Joseph F. Cavallari, Emmanuel Denou, Wendy Chi, James Lally, Justin D. Crane, Brittany M. Duggan, Kevin P. Foley, Morgan D. Fullerton, Mark A. Tarnopolsky, Gregory R. Steinberg, Jonathan D. Schertzer

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: